AKTIS ONCOLOGY, INC. - Common Stock (AKTSQ)

CUSIP: 00973N102

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / Common Stock
Shares outstanding
53,160,953
Total 13F shares
3,172,819
Share change
+411,188
Total reported value
$18,477,690
Price per share
$5.83
Number of holders
41
Value change
+$2,383,631
Number of buys
23
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 00973N102?
CUSIP 00973N102 identifies AKTSQ - AKTIS ONCOLOGY, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AKTSQ - AKTIS ONCOLOGY, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
HERALD INVESTMENT MANAGEMENT Ltd
13F
Company
1.1%
578,636
$3,610,000 31 Dec 2017
13F
VANGUARD GROUP INC
13F
Company
0.79%
421,294
$2,625,000 31 Dec 2017
13F
BlackRock Finance, Inc.
13F
Company
0.75%
400,293
$2,494,000 31 Dec 2017
13F
PRECEPT MANAGEMENT LLC
13F
Company
0.45%
240,000
$1,495,000 31 Dec 2017
13F
Financial Advocates Investment Management
13F
Company
0.3%
157,950
$984,000 31 Dec 2017
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.28%
146,531
$913,000 31 Dec 2017
13F
STATE STREET CORP
13F
Company
0.2%
104,604
$652,000 31 Dec 2017
13F
NORTHERN TRUST CORP
13F
Company
0.19%
98,509
$614,000 31 Dec 2017
13F
D.A. DAVIDSON & CO.
13F
Company
0.18%
94,000
$586,000 31 Dec 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.14%
76,656
$477,000 31 Dec 2017
13F
Providence Capital Advisors, LLC
13F
Company
0.13%
70,573
$440,000 31 Dec 2017
13F
UBS Group AG
13F
Company
0.12%
64,640
$403,000 31 Dec 2017
13F
MORGAN STANLEY
13F
Company
0.06%
30,821
$192,000 31 Dec 2017
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.06%
30,750
$192,000 31 Dec 2017
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.05%
28,991
$181,000 31 Dec 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.05%
28,983
$179,000 31 Dec 2017
13F
Bank of New York Mellon Corp
13F
Company
0.05%
24,049
$150,000 31 Dec 2017
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.04%
21,100
$132,000 31 Dec 2017
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.04%
18,904
$118,000 31 Dec 2017
13F
IHT Wealth Management, LLC
13F
Company
0.03%
15,281
$101,000 31 Dec 2017
13F
HBK Sorce Advisory LLC
13F
Company
0.03%
14,950
$93,000 31 Dec 2017
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.02%
12,968
$81,000 31 Dec 2017
13F
THOMPSON DAVIS & CO., INC.
13F
Company
0.02%
12,500
$78,000 31 Dec 2017
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.02%
10,789
$67,000 31 Dec 2017
13F
TEACHERS ADVISORS, LLC
13F
Company
0.02%
10,319
$64,000 31 Dec 2017
13F
BOARDMAN BAY CAPITAL MANAGEMENT LLC
13F
Company
0.02%
10,000
$62,000 31 Dec 2017
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.02%
8,078
$50,000 31 Dec 2017
13F
MACQUARIE GROUP LTD
13F
Company
0.01%
5,600
$35,000 31 Dec 2017
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.01%
3,400
$21,000 31 Dec 2017
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.01%
3,356
$20,908 31 Dec 2017
13F
Parallax Volatility Advisers, L.P.
13F
Company
0%
2,604
$16,000 31 Dec 2017
13F
JPMORGAN CHASE & CO
13F
Company
0%
2,588
$16,000 31 Dec 2017
13F
Legal & General Group Plc
13F
Company
0%
2,579
$16,000 31 Dec 2017
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0%
2,249
$14,000 31 Dec 2017
13F
BARCLAYS PLC
13F
Company
0%
1,901
$12,000 31 Dec 2017
13F
CITIGROUP INC
13F
Company
0%
1,222
$8,000 31 Dec 2017
13F
RBC Europe Ltd
13F
Company
0%
1,224
$7,626 31 Dec 2017
13F
Advisory Services Network, LLC
13F
Company
0%
1,200
$7,000 31 Dec 2017
13F
Ameritas Investment Partners, Inc.
13F
Company
0%
762
$5,000 31 Dec 2017
13F
BANK OF MONTREAL /CAN/
13F
Company
0%
381
$2,000 31 Dec 2017
13F
MGO ONE SEVEN LLC
13F
Company
0%
300
$2,000 31 Dec 2017
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0%
200
$1,000 31 Dec 2017
13F

Institutional Holders of AKTIS ONCOLOGY, INC. - Common Stock (AKTSQ) as of Q1 2018

As of 31 Mar 2018, AKTIS ONCOLOGY, INC. - Common Stock (AKTSQ) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,172,819 shares. The largest 10 holders included VANGUARD GROUP INC, Herald Investment Management Ltd, BlackRock Inc., Precept Management LLC, Financial Advocates Investment Management, NORTHERN TRUST CORP, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, D.A. DAVIDSON & CO., and UBS Group AG. This page lists 41 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders
42
Q1 2018 holders
41
Holder diff
-1
Investor Q4 2017 Shares Q1 2018 Shares Share Diff Share Chg % Q4 2017 Value $ Q1 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.